Simply Wall St.
A Look At CytomX Therapeutics (CTMX) Valuation After Positive Varsetatug Masetecan Phase 1 Expansion Results
📊
AI Sentiment
Positive
7/10
CytomX Therapeutics Inc. News
Latest updates and market news for CTMX
8 news
Mar 18 - Mar 24, 2026
Page 1
Insider Monkey
Jefferies Raises CytomX Therapeutics (CTMX) Price Target to $16
📈
AI Sentiment
Highly Positive
9/10
MT Newswires
Cytomx Therapeutics Insider Sold Shares Worth $764,138, According to a Recent SEC Filing
📉
AI Sentiment
Negative
3/10
MT Newswires
Sector Update: Health Care Stocks Lower in Afternoon Trading
📉
AI Sentiment
Negative
3/10
MT Newswires
Sector Update: Health Care Stocks Decline Premarket Wednesday
📉
AI Sentiment
Negative
3/10
MT Newswires
CytomX Therapeutics Prices $250 Million Securities Offering; Shares Up Pre-Bell
âž–
AI Sentiment
Neutral
5/10
GlobeNewswire
CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
📊
AI Sentiment
Positive
6/10
Share this news page